The 3D-printed product supplier raised an eight-digit dollar amount in a round featuring Chinese Academy of Sciences.

Zhejiang Xunshi Technology, a China-based 3D printing services provider, has raised tens of millions of dollars in a series C round featuring Chinese Academy of Sciences’ CAS Star unit, DealStreetAsia reported yesterday. Insurance firm China Life led the round through China Life Private Equity Investment Company and was also joined by Sinopharm Capital, the investment arm of pharmaceutical firm Sinopharm, as well as Qianhai FOF, Kunlun Fund and Keqiao Industry Fund. Founded in 2013, Xunshi provides 3D-printed products for customers in industries such as dentistry, healthcare, industrial manufacturing and consumer products. The capital will fund the launch of the company’s next generation of dental-focused printers and support international growth. It had raised $14.2m in an October 2019 series B round co-led by CD Capital and Marathon Venture Partners. – A version of this article first appeared on our sister site, Global Corporate Venturing.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?